Close Menu

NEW YORK — Drug developer Sorrento Therapeutics said on Wednesday that it has licensed a rapid point-of-care SARS-CoV-2 test from Columbia University.

According to the San Diego-based company, the reverse transcription loop-mediated isothermal amplification (RT-LAMP)-based test involves placing a saliva or nasopharyngeal swab sample into a tube that is warmed in a heat block or water bath. A colorimetric readout is provided within 30 minutes, confirming the presence or absence of viral RNA.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.